Oscor
1
20M
1
0.03
1
- Areas of investment
Summary
In 1982 was created Oscor, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Palm Harbor. The fund was located in North America if to be more exact in United States.
The fund is generally included in less than 2 deals every year. The top activity for fund was in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Oscor, startups are often financed by Originate Ventures, Life Sciences Greenhouse of Pennsylvania, Ben Franklin Technology Partners of Northeastern Pennsylvania. The meaningful sponsors for the fund in investment in the same round are Originate Ventures, Life Sciences Greenhouse of Pennsylvania, Ben Franklin Technology Partners of Northeastern Pennsylvania.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Micro Interventional Devices. Among the most successful fund investment fields, there are Manufacturing, Medical Device.
The fund was created by Peter Osypka.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 1
- Rounds per year
- 0.03
- Investments by industry
- Manufacturing (1)
- Medical Device (1)
- Health Care (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.